The Cigna Group · NYSE:CI

The Cigna — Cigna — Investor Presentation (May 2016)

25 slides from The Cigna's investor presentation, May 2016

  1. Slide 1: Cigna Global Supplemental Benefits

    CIGNA GLOBAL SUPPLEMENTAL BENEFITS © 2016 Cigna 1

  2. Slide 2: Forward looking statements and non-GAAP measures

    Forward looking statements and non-GAAP measures CAUTIONARY STATEMENT FOR PURPOSES OF THE “SAFE HARBOR” PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This presentation, and oral statements made with respect to information contained in this release, may contain forward-looking st

  3. Slide 3: Important information for investors

    Important information for investors NO OFFER OR SOLICITATION This communication is neither an offer to buy, nor a solicitation of an offer to sell, subscribe for or buy any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed trans

  4. Slide 4: Table of contents

    Table of contents  Global Supplemental Benefits Strategy  Business Overview  Market dynamics and core capabilities  Market specifics  Competitive environment © 2016 Cigna 4

  5. Slide 5: Alignment with enterprise strategy

    Alignment with enterprise strategy Go Go Go Deep Global Individual Strategic Affordability imperatives Personalization Enablers Insights Brand Localization Talent Value-based solutions focused on meeting customer needs © 2016 Cigna 5

  6. Slide 6: Business overview

    Business overview Serving 10 million individual customer relationships through a wide range of innovative and easy-to-access solutions to help improve their health, well-being and sense of security. China • Hong Kong • India • Indonesia • Korea • New Zealand • Taiwan • Thailand • Turkey • U.K. • U.S

  7. Slide 7: Strong growth and performance over a multi year period

    Strong growth and performance over a multi year period Revenue Earnings* (in $ millions) (in $ millions) 19% CAGR 26% CAGR Top and bottom line growth rates well exceed average of primary competitors^ *Adjusted income from operations ^Primary competitors include ACE, AEGON, AIA, Allianz, AXA, BUPA, M

  8. Slide 8: Broad portfolio of products and distribution channels

    Broad portfolio of products and distribution channels 2015 Sales by Product 2015 Sales by Distribution Channel Private Medical Term Life, 3% Credit, 3% Insurance, 4% Direct to Consumer, 21% VUL, 5% Med Supp, 9% Bancassurance, 42% Accident & Health, 39% Travel, 10% Affinity, 37% Protection & Savings,

  9. Slide 9: How we win

    How we win  Leveraging deep consumer insights to drive product innovation  Meeting the rapidly growing demand for health protection needs  Targeting the growing middle class and seniors populations globally  Leading innovative, direct to consumer distribution capabilities (over 150 affinity part

  10. Slide 10: Market dynamics

    Market dynamics Spending by the Asian middle class estimated to potentially rise 9% Growing Middle annually through 2030, driven by growth in China, India and Indonesia1 Class Growing awareness of health and well being and growing trend of non communicable diseases (diabetes, cancer) Health coverage

  11. Slide 11: Our core capabilities are tailored to local markets

    Our core capabilities are tailored to local markets Distribution and Deep Consumer Tailored Product Service Insights Innovation Capabilities Ability to leverage best-in- Leverage customer insights Understanding customer class, multi-channel and patented analytics needs through focused distribution c

  12. Slide 12: Direct marketing and partnership capabilities

    Direct marketing and partnership capabilities Globally, Cigna is a leader in direct marketing and providing leading health, life protection, accident and medical solutions We have a long history of working in partnership with other businesses including multinational and local banks, credit card comp

  13. Slide 13: Customer value management and tailored product innovation

    Customer value management and tailored product innovation Affinity Customer Access Partner Prior Experience and Relationships Other Distribution Opportunities Right Customer Right Product Deep Customer Insights CVM Analytics Right Time Segmentation Innovative Insurance Solutions CVM model is replica

  14. Slide 14: A portfolio approach to growth

    A portfolio approach to growth Market Development Progression Phase 4 Products and Distribution Korea Phase 3 Diverse and sophisticated product-set China Broad set of established Phase 2 distribution channels – Life, A&H, private medical affinity, home-shopping, bancassurance, agency… Thailand Multi

  15. Slide 15: Global Supplemental Benefits markets: Korea

    Global Supplemental Benefits markets Korea  Est. in 1987, the first foreign life insurer to enter Korea  Approximately 50% of Global Supplemental Benefits revenues  Expect mid teens growth in a low single digit growth market  Total policy count: 5.5M  Key Products:  Personal Accident, Cancer,

  16. Slide 16: Global Supplemental Benefits markets: United States, China

    Global Supplemental Benefits markets United States  Est. in 2012 with the purchase of Great American Supplemental Benefits  Total policy count: 400K  Key Products:  Medicare Supplement, Critical Illness  Primary Distribution: Primarily Broker, Some Direct to Consumer China  Est. in 2003 as a 5

  17. Slide 17: Global Supplemental Benefits markets: Taiwan, United Kingdom

    Global Supplemental Benefits markets Taiwan  Est. in 1989 / growth driven by strong affinity relationships (e.g. Watsons, Citi, ANZ)  Total policy count: 700K  Key Products:  Personal Accident, Cancer, Critical Illness, Dementia, Hospital Income, Surgical, Term Life, Whole Life, VUL, Dental and

  18. Slide 18: Global Supplemental Benefits markets: Turkey, Hong Kong

    Global Supplemental Benefits markets Turkey  Began 51% share JV partnership with Finansbank, 5th largest private retail bank in Turkey, in 2012  Total policy count: 1.7M  Key Products:  Credit Life, Personal Accident, Cancer, Critical Illness, Dental and Vision, and Pension  Primary Distributio

  19. Slide 19: Global Supplemental Benefits markets: Thailand, Indonesia

    Global Supplemental Benefits markets Thailand  Est. in 2006 / market has traditionally been a life insurance market distributed by brokers  Total policy count: 600K  Key Products:  Personal Accident, Cancer, Critical Illness, Hospital Income, Dental and Vision  Primary Distribution: Affinity /

  20. Slide 20: Global Supplemental Benefits markets: New Zealand, India

    Global Supplemental Benefits markets New Zealand  Market is aging and beginning to shift from life & accident to health related products  Total policy count: 300K  Key Products:  Personal Accident, Critical Illness, Term Life, Credit Life, and Travel  Primary Distribution: Direct marketing and

  21. Slide 21: Global Individual Private Medical Insurance

    Global Supplemental Benefits markets Global Individual Private Medical Insurance  Established in 2011 with 7 Global sites across the United States, European Union, and Asia Pacific  Total policy count: 14K  Key Products:  Global health insurance  Primary Distribution: Affinity, Broker and Direc

  22. Slide 22: Cigna faces a mix of local and global competitors in Asia

    Cigna faces a mix of local and global competitors in Asia China Korea Hong Kong  AIA  ACE  AIA  AXA  AIA  AXA  China Life  Kyobo  BUPA  Manulife  MetLife  Manulife  Ping An  Samsung Life  Prudential UK India Taiwan  Apollo Munich  ACE  BUPA  AIA  New India Assurance  Allianz  R

  23. Slide 23: Top priorities for our future growth

    Top priorities for our future growth • Continued focus on core direct marketing distribution with ongoing Ongoing improvements to segmentation, product development and upsell momentum in opportunities Korea • Test new direct to consumer techniques to diversify distribution • Leverage China Merchants

  24. Slide 24: Investor considerations

    Investor considerations Deep customer insights Drives Differentiated distribution capabilities mid teens Competitively top line and attractive long CVM analytics bottom line term outlook growth over Innovative product solutions that fill health gaps the long term Locally licensed and managed by loca

  25. Slide 25: Offered by Connecticut General Life Insurance Company or Cigna Health and Life

    Offered by: Connecticut General Life Insurance Company or Cigna Health and Life Insurance Company. “Cigna” and the “Tree of Life” logo are registered service marks, and “Together, all the way.” is a service mark, of Cigna Intellectual Property, Inc., licensed for use by Cigna Corporation and its ope

Cigna — Investor Presentation (May 2016) on 6ix